Search results for: Department of Molecular and Cell Biology, National Institute of Chemical Safety, "József Fodor" National Center for Public Health, Budapest, Hungary

Kocsis Z, Marcsek Z, Tompa A (2003): Chemopreventive role of Avemar in decreasing the cytotoxic effect of xenobiotics. Journal of the International Society for Advanced Cytometry.
PDF
Tompa A, Kocsis Z, Marcsek Z, Jakab M, Szende B, Hidvégi M (2003): Chemoprevention with Tamoxifen and Avemar by inducing apoptosis on MCF-7 (ER+) Breast cancer cells. In: 2nd Congress of the World Society for Breast Health. Monduzzi Editore, Bologna, p. 61-6.
PDF
Szende B, Marcsek Z, Kocsis Z, Tompa A (2004): Effect of simultaneous administration of Avemar and cytostatic drugs on viability of cell cultures, growth of experimental tumors, and survival of tumor-bearing mice. Cancer Biother Radiopharm. 19(3):343-9.
PDF
Marcsek Z, Kocsis Z, Jakab M, Szende B, Tompa A (2004): The efficacy of tamoxifen in estrogen receptor–positive breast cancer cells is enhanced by a medical nutriment. Cancer Biother Radiopharm. 19(6):746-53.
PDF

Search publications